Larisa Ryvo

675 total citations
13 papers, 312 citations indexed

About

Larisa Ryvo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Larisa Ryvo has authored 13 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 2 papers in Immunology. Recurrent topics in Larisa Ryvo's work include Advanced Breast Cancer Therapies (5 papers), Cancer Treatment and Pharmacology (5 papers) and HER2/EGFR in Cancer Research (4 papers). Larisa Ryvo is often cited by papers focused on Advanced Breast Cancer Therapies (5 papers), Cancer Treatment and Pharmacology (5 papers) and HER2/EGFR in Cancer Research (4 papers). Larisa Ryvo collaborates with scholars based in Israel, United States and Spain. Larisa Ryvo's co-authors include Alexander Shtabsky, Leonor Leider–Trejo, Neora Yaal‐Hahoshen, Sima Shina, Adit Ben‐Baruch, Iafa Keydar, Moshe Inbar, Tsipi Meshel, Marcelo Ehrlich and Gali Soria and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and The Lancet Oncology.

In The Last Decade

Larisa Ryvo

11 papers receiving 310 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Larisa Ryvo Israel 8 239 83 76 68 64 13 312
Paolo Marolla Italy 10 170 0.7× 24 0.3× 39 0.5× 77 1.1× 70 1.1× 16 322
Colin Purcell United Kingdom 5 180 0.8× 54 0.7× 117 1.5× 86 1.3× 55 0.9× 8 297
Samira Kamrudin United States 3 156 0.7× 48 0.6× 24 0.3× 63 0.9× 124 1.9× 6 278
Tsuyoshi Kuroda Japan 6 195 0.8× 59 0.7× 90 1.2× 175 2.6× 87 1.4× 10 368
Judy-Anne W. Chapman Canada 8 185 0.8× 38 0.5× 18 0.2× 85 1.3× 124 1.9× 9 358
Katrien Geboers Belgium 2 188 0.8× 28 0.3× 86 1.1× 101 1.5× 61 1.0× 2 288
Philippe Huget Belgium 6 256 1.1× 51 0.6× 97 1.3× 116 1.7× 79 1.2× 6 395
Ryan J. March United States 7 90 0.4× 68 0.8× 42 0.6× 101 1.5× 24 0.4× 8 238
Federica Gaudino Italy 9 126 0.5× 18 0.2× 92 1.2× 175 2.6× 84 1.3× 9 348
Simone Scagnoli Italy 12 293 1.2× 142 1.7× 121 1.6× 109 1.6× 83 1.3× 41 464

Countries citing papers authored by Larisa Ryvo

Since Specialization
Citations

This map shows the geographic impact of Larisa Ryvo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larisa Ryvo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larisa Ryvo more than expected).

Fields of papers citing papers by Larisa Ryvo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Larisa Ryvo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larisa Ryvo. The network helps show where Larisa Ryvo may publish in the future.

Co-authorship network of co-authors of Larisa Ryvo

This figure shows the co-authorship network connecting the top 25 collaborators of Larisa Ryvo. A scholar is included among the top collaborators of Larisa Ryvo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Larisa Ryvo. Larisa Ryvo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Abuhasira, Ran, Yosef S. Haviv, Merav Leiba, et al.. (2021). Cannabis is associated with blood pressure reduction in older adults – A 24-hours ambulatory blood pressure monitoring study. European Journal of Internal Medicine. 86. 79–85. 17 indexed citations
2.
Saura, Cristina, Larisa Ryvo, Sara A. Hurvitz, et al.. (2021). Abstract PD13-09: Impact of neratinib on outcomes in HER2-positive metastatic breast cancer patients with central nervous system disease at baseline: Findings from the phase 3 NALA trial. Cancer Research. 81(4_Supplement). PD13–9. 2 indexed citations
3.
Hirsh‐Yechezkel, Galit, Sivan Ben‐Avraham, Abed Agbarya, et al.. (2021). Oncology Treatments during the COVID-19 Pandemic in Israel: the ONCOR Study.. PubMed. 23(12). 759–765.
4.
5.
Janni, Wolfgang, Emilio Alba, Thomas Bachelot, et al.. (2018). First-line ribociclib plus letrozole in postmenopausal women with HR+ , HER2− advanced breast cancer: Tumor response and pain reduction in the phase 3 MONALEESA-2 trial. Breast Cancer Research and Treatment. 169(3). 469–479. 35 indexed citations
6.
Adams, Sylvia, Sherene Loi, Deborah Toppmeyer, et al.. (2017). Phase 2 study of pembrolizumab as first-line therapy for PD-L1–positive metastatic triple-negative breast cancer (mTNBC): Preliminary data from KEYNOTE-086 cohort B.. Journal of Clinical Oncology. 35(15_suppl). 1088–1088. 55 indexed citations
7.
Safra, Tamar, Bella Kaufman, Luna Kadouri, et al.. (2017). Everolimus Plus Letrozole for Treatment of Patients With HR+, HER2– Advanced Breast Cancer Progressing on Endocrine Therapy: An Open-label, Phase II Trial. Clinical Breast Cancer. 18(2). e197–e203. 11 indexed citations
8.
Janni, Wolfgang, Emilio Alba, Thomas Bachelot, et al.. (2017). Duration of response and tumor shrinkage with first-line ribociclib + letrozole in postmenopausal women with HR+, HER2– ABC. Annals of Oncology. 28. v78–v78. 1 indexed citations
9.
Ryvo, Larisa, et al.. (2017). Acupuncture and Reflexology for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer. Integrative Cancer Therapies. 16(3). 258–262. 32 indexed citations
10.
Stemmer, Salomon M., Michael Steiner, Shulamith Rizel, et al.. (2015). 1963 First prospective outcome data in 930 patients with more than 5 year median follow up in whom treatment decisions in clinical practice have been made incorporating the 21-Gene Recurrence Score. European Journal of Cancer. 51. S321–S321. 6 indexed citations
11.
12.
Soria, Gali, Neora Yaal‐Hahoshen, Sima Shina, et al.. (2008). Concomitant expression of the chemokines RANTES and MCP-1 in human breast cancer: A basis for tumor-promoting interactions. Cytokine. 44(1). 191–200. 78 indexed citations
13.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paolo Marolla Breakdown of academic impact, for papers by Colin Purcell Breakdown of academic impact, for papers by Samira Kamrudin Breakdown of academic impact, for papers by Tsuyoshi Kuroda Breakdown of academic impact, for papers by Judy-Anne W. Chapman Breakdown of academic impact, for papers by Katrien Geboers Breakdown of academic impact, for papers by Philippe Huget Breakdown of academic impact, for papers by Ryan J. March Breakdown of academic impact, for papers by Federica Gaudino Breakdown of academic impact, for papers by Simone Scagnoli
Rankless by CCL
2026